Trial intelligence / Profile preview

PMF104 versus KLEAN-PREP for bowel cleansing before colon procedures in children and adolescents

2015-002969-27Phase 3Terminated

Sponsor
Alfasigma
Start
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of polyethylene glycol 3350 + electrolytes (2 arms), sponsored by Alfasigma. Primary endpoint: Colon cleansing efficacy. Started Sep 2015; status: terminated.

02

Drugs

polyethylene glycol 3350 + electrolytes

Beyond the preview

Go deeper on 2015-002969-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-002969-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call